BackChi Sheng Pharma & Biotech , Ltd Overview

Chi Sheng Pharma & Biotech , Ltd Current Assets

Latest current assets for 4111.TWO: $980M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$976.02M
↑ 16.48% YoYΔ $138.09M vs prior year quarter

Peer trimmed avg / median

Loading

Chi Sheng Pharma & Biotech , Ltd Current Assets History

Loading

Chi Sheng Pharma & Biotech , Ltd vs. peers: Current Assets Comparison

Loading

Chi Sheng Pharma & Biotech , Ltd Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Chi Sheng Pharma & Biotech , Ltd (4111.TWO) FAQ

The latest current assets for 4111.TWO is $980M as of June 2026. That compares with $840M in the prior-year period — up 16.5% year over year. Investors often review this figure alongside Chi Sheng Pharma & Biotech , Ltd's historical trend and sector peers before judging valuation or financial health.

Over the past year, 4111.TWO's current assets moved from $840M to $980M — a 16.5% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Chi Sheng Pharma & Biotech , Ltd's operating scale or balance-sheet position.

A current assets figure of $980M for 4111.TWO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 4111.TWO's current assets ($980M), review year-over-year change from $840M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.